Abstract:1086 Objectives: In this study, arginine-arginine-leucine (RRL) a tumor targeting peptide is designed to link the bifunctional chelator mercaptoacetyltriglycine (MAG3), aiming to explore the labeling conditions of Tc-99m and to evaluate the imaging of this probe in vivo. Methods: Tc-99m was labeled through the SnCl2 reduction method, and the main factors affecting the labeling were investigated respectively to obtain the suitable labeling conditions. The paper chromatography was used to determine the labeling rate and radiochemical purity. Cysteine replacement experiment and incubation experiment of normal saline/bovine serum albumin was utilized to evaluate the stability of Tc-99m-MAG3-RRL in vitro. HepG2 tumor-bearing models were established and after tail vein injection, gamma camera imaging and biodistribution study were respectively performed periodically. Results: The purity of MAG3-RRL was 98.94%. Under the suitable labeling conditions, the labeling rate was 93.67% ± 1.10%, and the radiochemical purity was 94.32% ± 0.19% (n=3). Tc-99m-MAG3-RRL was placed in normal saline at room temperature and 50% BSA at 37 ℃, the radiochemical purity of Tc-99m-MAG3-RRL was more than 90% (n=3) within 6 hours. The highest replacement rate of Tc-99m-MAG3-RRL was 0.57% ± 0.21% in cysteine solution, and 0.41% ± 0.04% in normal saline control (n=3, P>0.05). The distribution coefficient IgP of Tc-99m-MAG3-RRL was -0.15 ± 0.01 (n=3). Gamma camera imaging revealed substantial uptake of Tc-99m-MAG3-RRL in tumors. The specific uptake of Tc-99m-MAG3-RRL in tumor was significantly higher than that of control test after injection (P<0.05). In planar gamma imaging study, the tumors were imaged clearly at 2-4h after injection of Tc-99m-MAG3-RRL, with the highest tumor-to-muscle ratio 5.63 ± 0.40 in 30min. Biodistribution data showed that Tc-99m-MAG3-RRL was rapidly accumulated in tumor within 30min with the highest tumor-to-muscle ratio 5.50 ± 0.74. And then it was rapidly cleared from the blood and predominantly accumulated in the kidneys. Conclusions: The results show that MAG3 could successfully be connected to RRL polypeptide and further improve the labeling rate, and the preparation method of Tc-99m-MAG3-RRL is simple and fast. Tc-99m-MAG3-RRL probe has good stability in vitro. Animal study shows that Tc-99m-MAG3-RRL can be used as a potential candidate for visualization of malignant carcinomas. Keywords: Arginine-Arginine-Leucine; Tc-99m; MAG3

Radiolabeling of Filamentous Phage Peptide Library with ~(99m)tc and Its Biodistribution in Normal Mice

Biodistribution of filamentous phage-Fab in nude mice

Biodistribution and Pharmacokinetics of 99tcm Labeled Carbohydrated Peptides in Mice Bearing Tumors

Biodistribution and SPECT Imaging Study Of99mtc Labeling NGR Peptide in Nude Mice Bearing Human HepG2 Hepatoma

[Radio-labeling of T7 peptide with 99mTc and its biodistribution in nude mice bearing non-small cell lung cancer].

Studies on distribution and imaging of 131I-labelled RGD peptide in mice bearing tumors

Radiolabeling LyP-1 Peptide and Preliminary Biodistribution Evaluation in Mice Bearing MDA-MB-435 Xenografts.

Radiolabeling and Biodistribution of a Nasopharyngeal Carcinoma-Targeting Peptide Identified by in Vivo Phage Display.

SYNTHESIS OF LABELED PEPTIDE COMPLEXES WITH TECHNETIUM-99m AND BIODISTRIBUTION IN MICE

Synthesis of Labelled Small Peptide Complexes for Imaging Agents with Technetium-99M and Biodistribution in Mice.

Screening, Radiolabeling and Biodistribution of Lung Tumor-targeting Peptide YC11 by in vivo Phage Display

Preparation of ~(99)Tc~m-TP1093 and its bio-distribution and kinetic characteristics in healthy animals

A Novel Tc-99m-labeled and MAG<sub>3</sub>-chelated Arginine-Arginine-Leucine containing Peptide for Tumor Imaging in Hepatoma Xenografts Model

Preparation of ~(99)Tc~m-Dtpa-folate and Biodistribution Study in Athymic Mice

Synthesis and Biodistribution of 99Tcm-MAG2-Ade as A Tumor Imaging Agent

Comparing two TAG-72 binding peptides previously identified by phage display as potential imaging agents.

188Re Radiolabeling RGD Peptide and Preliminary Biodistribution Evaluation in Mice Bearing S180 Tumors

Screening Tumor-Targeting Bacteriophage Particles by Pre-Clearing Phage Display

Identification of a High Affinity TAG-72 Binding Peptide by Phage Display Selection

Transplanted Murine Tumours SPECT Imaging with 99mTc Delivered with an Artificial Recombinant Protein

Synthesis and Biodistribution of 99Mtc-Peptides Conjugated Adenine As Tumor Imaging Agents